EMBOCEPT
Live / Registered — Registered — international registration renewed (as of 04 Feb 2024)
What this means for you
Registered since 06 Jun 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 ten-year affidavit of use is due by 06 Jun 2027, and its filing window is open now).
Record
- Serial number
- 79200744
- Registration number
- 5215890
- Mark type
- Word mark
- Filed
- 18 Oct 2016
- Published for opposition
- 21 Mar 2017
- Registered
- 06 Jun 2017
- Next maintenance filing
- §71 ten-year affidavit of use, due by 06 Jun 2027 (grace period to 06 Dec 2027)
- Attorney of record
- Max Moskowitz
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, embolisates
Owner
- PharmaCept GmbH, DE
- PharmaCept GmbH, DE
- PharmaCept GmbH, DE
Prosecution history
- 06 Jun 2026 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 25 Sept 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 04 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 04 Feb 2024 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 04 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 May 2023 — TEAS SECTION 71 & 15 RECEIVED
- 28 Apr 2022 — CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 20 Mar 2022 — CORRECTION TRANSACTION RECEIVED FROM IB
- 11 Mar 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 04 Mar 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 12 Nov 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 20 Mar 2020 — NEW REPRESENTATIVE AT IB RECEIVED
- 28 Jul 2017 — NOTIFICATION PROCESSED BY IB
- 07 Jul 2017 — FINAL DISPOSITION NOTICE SENT TO IB
- 07 Jul 2017 — FINAL DISPOSITION PROCESSED